Quintiles’ Infosario® Identity Management Solution Recognized in CSO50
RESEARCH TRIANGLE PARK, N.C. - Friday, April 22nd 2016 [ME NewsWire]
(BUSINESS WIRE)-- Quintiles, the world’s leading provider of biopharmaceutical services, announced today that it has been named to the 2016 CSO50 by IDG's CSO magazine. This award recognizes the company’s innovative identity management solution designed to expedite activities related to the delivery of clinical trials while simultaneously protecting confidential user data. This is the company’s fourth consecutive year receiving the prestigious security award.
Quintiles’ Identity Management Solution introduced identity vetting, identity storage and identity synchronization that improved data quality for both existing and newly established users. The resulting system supports faster business enablement of critical project activities including site start-up while reducing identity-based security risks.
“As a company operating in over 100 countries and executing trials with over 38,000 partner investigators globally, we recognized the need for a global, simplified solution,” said Charles Newberry, chief information security officer at Quintiles. “As more clinical development activities accelerate toward digital solutions, secure user access to systems and data that improve speed and accuracy are even more critical. The Identity Management Solution is designed with those trends in mind — simultaneously reducing administrative burden and expediting crucial clinical trial activities while maintaining the integrity and security of users’ data.”
Each year, the CSO50 Awards recognize 50 organizations for security projects and initiatives that demonstrate outstanding business value and thought leadership. Nominations are scored on a uniform set of criteria by a panel of judges including security leaders, industry experts, and academics. The final winning selections are made by CSO's editors based on this scoring process.
“We are honored to receive this award which reflects our world-class security team and software development teams who pioneered this innovative approach,” Newberry added.
“Security professionals know that securing an organization is about much more than mere defense today; it’s also about enabling business and driving ROI,” said Joan Goodchild, editor in chief, CSO. “Our annual CSO50 Awards recognize the innovation, creativity and business acumen that goes into creating outstanding security projects. We congratulate each of our winners for their accomplishments in creating projects that not only demonstrate state-of-the-art security, but exemplary business value as well.”
About Quintiles
Quintiles (NYSE: Q) helps biopharma and other healthcare companies improve their probability of success by connecting insights from our deep scientific, therapeutic and analytics expertise with superior delivery for better outcomes. From advisory through operations, Quintiles is the world’s largest provider of product development and integrated healthcare services, including commercial and observational solutions. Conducting operations in approximately 100 countries, Quintiles is a member of the Fortune 500 and has been named to Fortune’s list of the “World’s Most Admired Companies.” To learn more, visit www.quintiles.com.
Click here to subscribe to Mobile Alerts for Quintiles.
Contacts
Quintiles
Phil Bridges, Media Relations
Office: 1-919-998-1653
Mobile: 1-919-457-6347
phil.bridges@quintiles.com
Todd Kasper, Investor Relations
1-919-998-2590
todd.kasper@quintiles.com
Permalink: http://me-newswire.net/news/17674/en
RESEARCH TRIANGLE PARK, N.C. - Friday, April 22nd 2016 [ME NewsWire]
(BUSINESS WIRE)-- Quintiles, the world’s leading provider of biopharmaceutical services, announced today that it has been named to the 2016 CSO50 by IDG's CSO magazine. This award recognizes the company’s innovative identity management solution designed to expedite activities related to the delivery of clinical trials while simultaneously protecting confidential user data. This is the company’s fourth consecutive year receiving the prestigious security award.
Quintiles’ Identity Management Solution introduced identity vetting, identity storage and identity synchronization that improved data quality for both existing and newly established users. The resulting system supports faster business enablement of critical project activities including site start-up while reducing identity-based security risks.
“As a company operating in over 100 countries and executing trials with over 38,000 partner investigators globally, we recognized the need for a global, simplified solution,” said Charles Newberry, chief information security officer at Quintiles. “As more clinical development activities accelerate toward digital solutions, secure user access to systems and data that improve speed and accuracy are even more critical. The Identity Management Solution is designed with those trends in mind — simultaneously reducing administrative burden and expediting crucial clinical trial activities while maintaining the integrity and security of users’ data.”
Each year, the CSO50 Awards recognize 50 organizations for security projects and initiatives that demonstrate outstanding business value and thought leadership. Nominations are scored on a uniform set of criteria by a panel of judges including security leaders, industry experts, and academics. The final winning selections are made by CSO's editors based on this scoring process.
“We are honored to receive this award which reflects our world-class security team and software development teams who pioneered this innovative approach,” Newberry added.
“Security professionals know that securing an organization is about much more than mere defense today; it’s also about enabling business and driving ROI,” said Joan Goodchild, editor in chief, CSO. “Our annual CSO50 Awards recognize the innovation, creativity and business acumen that goes into creating outstanding security projects. We congratulate each of our winners for their accomplishments in creating projects that not only demonstrate state-of-the-art security, but exemplary business value as well.”
About Quintiles
Quintiles (NYSE: Q) helps biopharma and other healthcare companies improve their probability of success by connecting insights from our deep scientific, therapeutic and analytics expertise with superior delivery for better outcomes. From advisory through operations, Quintiles is the world’s largest provider of product development and integrated healthcare services, including commercial and observational solutions. Conducting operations in approximately 100 countries, Quintiles is a member of the Fortune 500 and has been named to Fortune’s list of the “World’s Most Admired Companies.” To learn more, visit www.quintiles.com.
Click here to subscribe to Mobile Alerts for Quintiles.
Contacts
Quintiles
Phil Bridges, Media Relations
Office: 1-919-998-1653
Mobile: 1-919-457-6347
phil.bridges@quintiles.com
Todd Kasper, Investor Relations
1-919-998-2590
todd.kasper@quintiles.com
Permalink: http://me-newswire.net/news/17674/en